Crossmark

No survival benefit of primary tumor resection for non-small cell lung cancer patients with unexpectedly detected pleural disseminated nodules in the era of targeted therapy

Crossref DOI link: https://doi.org/10.1007/s11748-024-02055-5

Published Online: 2024-07-20

Published Print: 2025-02

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Watanabe, Yukio

Takamochi, Kazuya

Hayashi, Takuo

Hattori, Aritoshi

Fukui, Mariko

Matsunaga, Takeshi

Tomita, Hisashi

Suzuki, Kenji
License Information

Text and Data Mining valid from 2024-07-20

Version of Record valid from 2024-07-20
More Information

Article History

Received: 16 March 2024

Accepted: 25 June 2024

First Online: 20 July 2024

Declarations

:

: All authors have no conflicts of interest to disclose.

: This retrospective study was performed under a waiver of authorization approved by the institutional review board of Juntendo University School of Medicine (19–131). Written informed consent to the patient was waived.

Document is current

Any future updates will be listed below